Ginkgo Bioworks

Counting down Boston’s biggest venture rounds from 2019

Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. Today, the last day of 2019, we’re taking a second look at Boston. Regular

Startups Weekly: Upfront Ventures bets on a bus service

In this week's newsletter: Airbnb, WeWork and Postmates prep IPOs.

Ginkgo Bioworks’ dev shop for genetic programming is now worth $4 billion

Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion that will give the company the cash to dramatically expand its developer shop for genetic programming. The Boston-based co

Boston gets a new biotech accelerator with the launch of Petri

As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch

Biotech researchers venture into the wild to start their own business

Much of Silicon Valley mythology is centered on the founder-as-hero narrative. But historically, scientific founders leading the charge for bio companies have been far less common.

Cannabis processing startups hope to unlock new chemicals and treatments

Jeff Ubersax knows yeast. The chief executive officer of Demetrix studied yeast genetics and biochemistry in school and was an early employee at Amyris Biotechnologies, a technology company that was u

From lab-grown meat to fermented fungus, here’s what corporate food VCs are serving up

We put together a list of venture funds operated by some of the larger food and beverage producers, covering literally everything from soup to nuts (plus lunch meat and soda, too!).

These are the most successful companies to emerge from Y Combinator

A look at the 20 most successful companies to come out of Y Combinator.

Ginkgo Bioworks secures $275 million in Series D, valuing the company at over $1 billion

Boston biotech startup Ginkgo Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Glo

Biotech startup Zymergen nabs $130 million from Softbank

Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes craz

Ginkgo Bioworks grabs $100 million in financing to buy a whole lot of synthetic DNA

Ginko Bioworks, the Boston-based biotech startup making all sorts of scents and flavors from microbugs, has pulled in $100 million in Series C funding to obtain 600 million base pairs of manufactured

Ginkgo Bioworks Takes On Zymergen With $45 Million In Series B Funding

Boston biotech startup Ginkgo Bioworks just gained an extra $45 million in Series B funding from an "oversubscribed" list of investors. The startup raised $9 million in March, so that gives the startu

Ginkgo Bioworks Lands $9 Million In Series A Funding To Build Out New Lab Facilities

Ginkgo Bioworks, the Boston-based startup working with DARPA and others on wild science projects involving bio-organisms, has just raised $9 Million in Series A Financing from Felicis Ventures, OS Fun

Why The First YC-Backed Biotech Company May Just Be The Future Of Pharma

Gingko Bioworks sounds kind of like a mad science lab of the future. The Boston-based biotech company is currently working on a project with DARPA to treat antibiotic-resistant germs, using designer